Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial

PURPOSE. To investigate the safety and preliminary efficacy of OT-551, a disubstituted hydroxylamine with antioxidant properties, for the treatment of geographic atrophy (GA), the advanced atrophic form of age-related macular degeneration (AMD). METHODS. The study was a single-center, open-label pha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wong, Wai T., Kam, Waynekid, Cunningham, Denise, Harrington, Molly, Hammel, Keri, Meyerle, Catherine B., Cukras, Catherine, Chew, Emily Y., Sadda, Srinivas R., Ferris, Frederick L.
Formato: Artigo
Idioma:Inglês
Publicado em: Association for Research in Vision and Ophthalmology, Inc. 2010
Assuntos:
Clinical Trials
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055748/
https://ncbi.nlm.nih.gov/pubmed/20574018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.10-5637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados